nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF1—Pazopanib—kidney cancer	0.681	1	CbGbCtD
Pentosan Polysulfate—Decreased appetite—Sorafenib—kidney cancer	0.000196	0.00132	CcSEcCtD
Pentosan Polysulfate—Anorexia—Dactinomycin—kidney cancer	0.000196	0.00132	CcSEcCtD
Pentosan Polysulfate—Nausea—Pazopanib—kidney cancer	0.000195	0.00132	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Doxorubicin—kidney cancer	0.000195	0.00132	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Doxorubicin—kidney cancer	0.000195	0.00132	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Sunitinib—kidney cancer	0.000195	0.00131	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Sunitinib—kidney cancer	0.000193	0.0013	CcSEcCtD
Pentosan Polysulfate—Constipation—Sorafenib—kidney cancer	0.000193	0.0013	CcSEcCtD
Pentosan Polysulfate—Malaise—Gemcitabine—kidney cancer	0.000192	0.0013	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Vinblastine—kidney cancer	0.000192	0.0013	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Capecitabine—kidney cancer	0.000192	0.00129	CcSEcCtD
Pentosan Polysulfate—Myalgia—Vincristine—kidney cancer	0.000191	0.00129	CcSEcCtD
Pentosan Polysulfate—Weight increased—Capecitabine—kidney cancer	0.000191	0.00129	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Everolimus—kidney cancer	0.000191	0.00129	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Paclitaxel—kidney cancer	0.000191	0.00129	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Sunitinib—kidney cancer	0.000191	0.00129	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Gemcitabine—kidney cancer	0.000191	0.00129	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Capecitabine—kidney cancer	0.00019	0.00128	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Sunitinib—kidney cancer	0.000188	0.00127	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000187	0.00126	CcSEcCtD
Pentosan Polysulfate—Depression—Capecitabine—kidney cancer	0.000187	0.00126	CcSEcCtD
Pentosan Polysulfate—Constipation—Sunitinib—kidney cancer	0.000185	0.00125	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Sorafenib—kidney cancer	0.000184	0.00124	CcSEcCtD
Pentosan Polysulfate—Pruritus—Everolimus—kidney cancer	0.000184	0.00124	CcSEcCtD
Pentosan Polysulfate—Oedema—Vincristine—kidney cancer	0.000183	0.00124	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Capecitabine—kidney cancer	0.000183	0.00123	CcSEcCtD
Pentosan Polysulfate—Jaundice—Capecitabine—kidney cancer	0.000183	0.00123	CcSEcCtD
Pentosan Polysulfate—Infection—Vincristine—kidney cancer	0.000182	0.00123	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Capecitabine—kidney cancer	0.000182	0.00123	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Gemcitabine—kidney cancer	0.000181	0.00122	CcSEcCtD
Pentosan Polysulfate—Myalgia—Gemcitabine—kidney cancer	0.000181	0.00122	CcSEcCtD
Pentosan Polysulfate—Alopecia—Paclitaxel—kidney cancer	0.000181	0.00122	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Vincristine—kidney cancer	0.00018	0.00121	CcSEcCtD
Pentosan Polysulfate—Discomfort—Gemcitabine—kidney cancer	0.000179	0.00121	CcSEcCtD
Pentosan Polysulfate—Urticaria—Sorafenib—kidney cancer	0.000179	0.00121	CcSEcCtD
Pentosan Polysulfate—Haematuria—Capecitabine—kidney cancer	0.000179	0.00121	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Doxorubicin—kidney cancer	0.000179	0.0012	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Dactinomycin—kidney cancer	0.000178	0.0012	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Vinblastine—kidney cancer	0.000178	0.0012	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Sorafenib—kidney cancer	0.000178	0.0012	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Everolimus—kidney cancer	0.000178	0.0012	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Sunitinib—kidney cancer	0.000177	0.0012	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Vincristine—kidney cancer	0.000177	0.0012	CcSEcCtD
Pentosan Polysulfate—Pruritus—Erlotinib—kidney cancer	0.000177	0.0012	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Capecitabine—kidney cancer	0.000177	0.00119	CcSEcCtD
Pentosan Polysulfate—Flatulence—Paclitaxel—kidney cancer	0.000176	0.00119	CcSEcCtD
Pentosan Polysulfate—Anorexia—Vincristine—kidney cancer	0.000175	0.00118	CcSEcCtD
Pentosan Polysulfate—Oedema—Gemcitabine—kidney cancer	0.000174	0.00117	CcSEcCtD
Pentosan Polysulfate—Infection—Gemcitabine—kidney cancer	0.000173	0.00117	CcSEcCtD
Pentosan Polysulfate—Dizziness—Vinblastine—kidney cancer	0.000172	0.00116	CcSEcCtD
Pentosan Polysulfate—Dizziness—Everolimus—kidney cancer	0.000172	0.00116	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Sunitinib—kidney cancer	0.000171	0.00116	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Erlotinib—kidney cancer	0.000171	0.00116	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Gemcitabine—kidney cancer	0.00017	0.00115	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Dactinomycin—kidney cancer	0.000169	0.00114	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Capecitabine—kidney cancer	0.000169	0.00114	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Gemcitabine—kidney cancer	0.000168	0.00113	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000168	0.00113	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000167	0.00113	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Capecitabine—kidney cancer	0.000167	0.00113	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Sorafenib—kidney cancer	0.000166	0.00112	CcSEcCtD
Pentosan Polysulfate—Insomnia—Vincristine—kidney cancer	0.000166	0.00112	CcSEcCtD
Pentosan Polysulfate—Anorexia—Gemcitabine—kidney cancer	0.000166	0.00112	CcSEcCtD
Pentosan Polysulfate—Vomiting—Vinblastine—kidney cancer	0.000166	0.00112	CcSEcCtD
Pentosan Polysulfate—Dizziness—Erlotinib—kidney cancer	0.000166	0.00112	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Paclitaxel—kidney cancer	0.000166	0.00112	CcSEcCtD
Pentosan Polysulfate—Vomiting—Everolimus—kidney cancer	0.000165	0.00111	CcSEcCtD
Pentosan Polysulfate—Anaemia—Paclitaxel—kidney cancer	0.000165	0.00111	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Vincristine—kidney cancer	0.000165	0.00111	CcSEcCtD
Pentosan Polysulfate—Agitation—Paclitaxel—kidney cancer	0.000164	0.00111	CcSEcCtD
Pentosan Polysulfate—Rash—Everolimus—kidney cancer	0.000164	0.0011	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Everolimus—kidney cancer	0.000164	0.0011	CcSEcCtD
Pentosan Polysulfate—Headache—Vinblastine—kidney cancer	0.000163	0.0011	CcSEcCtD
Pentosan Polysulfate—Headache—Everolimus—kidney cancer	0.000163	0.0011	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Dactinomycin—kidney cancer	0.000162	0.00109	CcSEcCtD
Pentosan Polysulfate—Malaise—Paclitaxel—kidney cancer	0.000161	0.00109	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Paclitaxel—kidney cancer	0.00016	0.00108	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Sunitinib—kidney cancer	0.00016	0.00108	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Vincristine—kidney cancer	0.000159	0.00108	CcSEcCtD
Pentosan Polysulfate—Pruritus—Sorafenib—kidney cancer	0.000159	0.00108	CcSEcCtD
Pentosan Polysulfate—Vomiting—Erlotinib—kidney cancer	0.000159	0.00107	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000158	0.00107	CcSEcCtD
Pentosan Polysulfate—Rash—Erlotinib—kidney cancer	0.000158	0.00107	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Erlotinib—kidney cancer	0.000158	0.00106	CcSEcCtD
Pentosan Polysulfate—Insomnia—Gemcitabine—kidney cancer	0.000157	0.00106	CcSEcCtD
Pentosan Polysulfate—Headache—Erlotinib—kidney cancer	0.000157	0.00106	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Capecitabine—kidney cancer	0.000157	0.00106	CcSEcCtD
Pentosan Polysulfate—Constipation—Vincristine—kidney cancer	0.000157	0.00106	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Gemcitabine—kidney cancer	0.000156	0.00105	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Gemcitabine—kidney cancer	0.000155	0.00105	CcSEcCtD
Pentosan Polysulfate—Nausea—Vinblastine—kidney cancer	0.000155	0.00104	CcSEcCtD
Pentosan Polysulfate—Affect lability—Doxorubicin—kidney cancer	0.000154	0.00104	CcSEcCtD
Pentosan Polysulfate—Nausea—Everolimus—kidney cancer	0.000154	0.00104	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Sorafenib—kidney cancer	0.000154	0.00104	CcSEcCtD
Pentosan Polysulfate—Pruritus—Sunitinib—kidney cancer	0.000153	0.00104	CcSEcCtD
Pentosan Polysulfate—Myalgia—Paclitaxel—kidney cancer	0.000152	0.00103	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Paclitaxel—kidney cancer	0.000152	0.00103	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Gemcitabine—kidney cancer	0.000151	0.00102	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Dactinomycin—kidney cancer	0.000151	0.00102	CcSEcCtD
Pentosan Polysulfate—Discomfort—Paclitaxel—kidney cancer	0.00015	0.00101	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Vincristine—kidney cancer	0.00015	0.00101	CcSEcCtD
Pentosan Polysulfate—Dizziness—Sorafenib—kidney cancer	0.000149	0.00101	CcSEcCtD
Pentosan Polysulfate—Constipation—Gemcitabine—kidney cancer	0.000149	0.001	CcSEcCtD
Pentosan Polysulfate—Nausea—Erlotinib—kidney cancer	0.000149	0.001	CcSEcCtD
Pentosan Polysulfate—Alopecia—Capecitabine—kidney cancer	0.000149	0.001	CcSEcCtD
Pentosan Polysulfate—Mood swings—Doxorubicin—kidney cancer	0.000148	0.001	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Sunitinib—kidney cancer	0.000148	0.001	CcSEcCtD
Pentosan Polysulfate—Dehydration—Doxorubicin—kidney cancer	0.000146	0.000984	CcSEcCtD
Pentosan Polysulfate—Oedema—Paclitaxel—kidney cancer	0.000146	0.000983	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Vincristine—kidney cancer	0.000145	0.000978	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Doxorubicin—kidney cancer	0.000145	0.000977	CcSEcCtD
Pentosan Polysulfate—Infection—Paclitaxel—kidney cancer	0.000145	0.000976	CcSEcCtD
Pentosan Polysulfate—Flatulence—Capecitabine—kidney cancer	0.000144	0.000974	CcSEcCtD
Pentosan Polysulfate—Dizziness—Sunitinib—kidney cancer	0.000143	0.000968	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Gemcitabine—kidney cancer	0.000143	0.000967	CcSEcCtD
Pentosan Polysulfate—Vomiting—Sorafenib—kidney cancer	0.000143	0.000967	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Paclitaxel—kidney cancer	0.000143	0.000962	CcSEcCtD
Pentosan Polysulfate—Rash—Sorafenib—kidney cancer	0.000142	0.000959	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Sorafenib—kidney cancer	0.000142	0.000958	CcSEcCtD
Pentosan Polysulfate—Headache—Sorafenib—kidney cancer	0.000141	0.000953	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Paclitaxel—kidney cancer	0.000141	0.00095	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Dactinomycin—kidney cancer	0.00014	0.000948	CcSEcCtD
Pentosan Polysulfate—Anorexia—Paclitaxel—kidney cancer	0.000139	0.000937	CcSEcCtD
Pentosan Polysulfate—Gastritis—Doxorubicin—kidney cancer	0.000139	0.000936	CcSEcCtD
Pentosan Polysulfate—Vomiting—Sunitinib—kidney cancer	0.000138	0.00093	CcSEcCtD
Pentosan Polysulfate—Rash—Sunitinib—kidney cancer	0.000137	0.000923	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Sunitinib—kidney cancer	0.000137	0.000922	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Capecitabine—kidney cancer	0.000136	0.000917	CcSEcCtD
Pentosan Polysulfate—Headache—Sunitinib—kidney cancer	0.000136	0.000917	CcSEcCtD
Pentosan Polysulfate—Anaemia—Capecitabine—kidney cancer	0.000135	0.000913	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Vincristine—kidney cancer	0.000135	0.000912	CcSEcCtD
Pentosan Polysulfate—Nausea—Sorafenib—kidney cancer	0.000134	0.000903	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000133	0.000896	CcSEcCtD
Pentosan Polysulfate—Malaise—Capecitabine—kidney cancer	0.000132	0.000891	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Doxorubicin—kidney cancer	0.000132	0.000891	CcSEcCtD
Pentosan Polysulfate—Insomnia—Paclitaxel—kidney cancer	0.000132	0.000889	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Capecitabine—kidney cancer	0.000131	0.000885	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Paclitaxel—kidney cancer	0.000131	0.000883	CcSEcCtD
Pentosan Polysulfate—Vomiting—Dactinomycin—kidney cancer	0.00013	0.000881	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Paclitaxel—kidney cancer	0.00013	0.000876	CcSEcCtD
Pentosan Polysulfate—Rash—Dactinomycin—kidney cancer	0.000129	0.000873	CcSEcCtD
Pentosan Polysulfate—Nausea—Sunitinib—kidney cancer	0.000129	0.000869	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Paclitaxel—kidney cancer	0.000128	0.000865	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Paclitaxel—kidney cancer	0.000127	0.000854	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Vincristine—kidney cancer	0.000125	0.000847	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Doxorubicin—kidney cancer	0.000125	0.000845	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Capecitabine—kidney cancer	0.000125	0.000841	CcSEcCtD
Pentosan Polysulfate—Myalgia—Capecitabine—kidney cancer	0.000125	0.000841	CcSEcCtD
Pentosan Polysulfate—Constipation—Paclitaxel—kidney cancer	0.000125	0.000841	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000124	0.000835	CcSEcCtD
Pentosan Polysulfate—Weight increased—Doxorubicin—kidney cancer	0.000123	0.000832	CcSEcCtD
Pentosan Polysulfate—Discomfort—Capecitabine—kidney cancer	0.000123	0.000831	CcSEcCtD
Pentosan Polysulfate—Pruritus—Gemcitabine—kidney cancer	0.000123	0.000831	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Doxorubicin—kidney cancer	0.000123	0.000827	CcSEcCtD
Pentosan Polysulfate—Nausea—Dactinomycin—kidney cancer	0.000122	0.000823	CcSEcCtD
Pentosan Polysulfate—Dizziness—Vincristine—kidney cancer	0.000121	0.000818	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Paclitaxel—kidney cancer	0.00012	0.00081	CcSEcCtD
Pentosan Polysulfate—Oedema—Capecitabine—kidney cancer	0.00012	0.000807	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000119	0.000804	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Gemcitabine—kidney cancer	0.000119	0.000803	CcSEcCtD
Pentosan Polysulfate—Infection—Capecitabine—kidney cancer	0.000119	0.000801	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Doxorubicin—kidney cancer	0.000118	0.000795	CcSEcCtD
Pentosan Polysulfate—Jaundice—Doxorubicin—kidney cancer	0.000118	0.000795	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Doxorubicin—kidney cancer	0.000117	0.000792	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Capecitabine—kidney cancer	0.000117	0.00079	CcSEcCtD
Pentosan Polysulfate—Vomiting—Vincristine—kidney cancer	0.000117	0.000787	CcSEcCtD
Pentosan Polysulfate—Sweating—Doxorubicin—kidney cancer	0.000116	0.000782	CcSEcCtD
Pentosan Polysulfate—Urticaria—Paclitaxel—kidney cancer	0.000116	0.000781	CcSEcCtD
Pentosan Polysulfate—Rash—Vincristine—kidney cancer	0.000116	0.00078	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Capecitabine—kidney cancer	0.000116	0.00078	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Vincristine—kidney cancer	0.000116	0.00078	CcSEcCtD
Pentosan Polysulfate—Haematuria—Doxorubicin—kidney cancer	0.000115	0.000777	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Paclitaxel—kidney cancer	0.000115	0.000777	CcSEcCtD
Pentosan Polysulfate—Headache—Vincristine—kidney cancer	0.000115	0.000775	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Doxorubicin—kidney cancer	0.000114	0.000769	CcSEcCtD
Pentosan Polysulfate—Anorexia—Capecitabine—kidney cancer	0.000114	0.000769	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Doxorubicin—kidney cancer	0.000113	0.000765	CcSEcCtD
Pentosan Polysulfate—Vomiting—Gemcitabine—kidney cancer	0.000111	0.000746	CcSEcCtD
Pentosan Polysulfate—Rash—Gemcitabine—kidney cancer	0.00011	0.00074	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Gemcitabine—kidney cancer	0.00011	0.00074	CcSEcCtD
Pentosan Polysulfate—Headache—Gemcitabine—kidney cancer	0.000109	0.000735	CcSEcCtD
Pentosan Polysulfate—Nausea—Vincristine—kidney cancer	0.000109	0.000735	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000109	0.000735	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Doxorubicin—kidney cancer	0.000109	0.000734	CcSEcCtD
Pentosan Polysulfate—Insomnia—Capecitabine—kidney cancer	0.000108	0.00073	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Doxorubicin—kidney cancer	0.000108	0.000726	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Capecitabine—kidney cancer	0.000107	0.000724	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Paclitaxel—kidney cancer	0.000107	0.000724	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Capecitabine—kidney cancer	0.000107	0.000719	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Capecitabine—kidney cancer	0.000105	0.00071	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Capecitabine—kidney cancer	0.000104	0.000701	CcSEcCtD
Pentosan Polysulfate—Nausea—Gemcitabine—kidney cancer	0.000103	0.000697	CcSEcCtD
Pentosan Polysulfate—Pruritus—Paclitaxel—kidney cancer	0.000103	0.000695	CcSEcCtD
Pentosan Polysulfate—Constipation—Capecitabine—kidney cancer	0.000102	0.00069	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Doxorubicin—kidney cancer	0.000101	0.000682	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Paclitaxel—kidney cancer	9.97e-05	0.000673	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Capecitabine—kidney cancer	9.85e-05	0.000665	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Capecitabine—kidney cancer	9.77e-05	0.00066	CcSEcCtD
Pentosan Polysulfate—Dizziness—Paclitaxel—kidney cancer	9.63e-05	0.00065	CcSEcCtD
Pentosan Polysulfate—Alopecia—Doxorubicin—kidney cancer	9.58e-05	0.000647	CcSEcCtD
Pentosan Polysulfate—Urticaria—Capecitabine—kidney cancer	9.49e-05	0.000641	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Capecitabine—kidney cancer	9.45e-05	0.000638	CcSEcCtD
Pentosan Polysulfate—Flatulence—Doxorubicin—kidney cancer	9.3e-05	0.000628	CcSEcCtD
Pentosan Polysulfate—Vomiting—Paclitaxel—kidney cancer	9.26e-05	0.000625	CcSEcCtD
Pentosan Polysulfate—Rash—Paclitaxel—kidney cancer	9.18e-05	0.00062	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Paclitaxel—kidney cancer	9.17e-05	0.000619	CcSEcCtD
Pentosan Polysulfate—Headache—Paclitaxel—kidney cancer	9.12e-05	0.000616	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Capecitabine—kidney cancer	8.81e-05	0.000594	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Doxorubicin—kidney cancer	8.76e-05	0.000591	CcSEcCtD
Pentosan Polysulfate—Anaemia—Doxorubicin—kidney cancer	8.73e-05	0.000589	CcSEcCtD
Pentosan Polysulfate—Agitation—Doxorubicin—kidney cancer	8.68e-05	0.000585	CcSEcCtD
Pentosan Polysulfate—Nausea—Paclitaxel—kidney cancer	8.65e-05	0.000584	CcSEcCtD
Pentosan Polysulfate—Malaise—Doxorubicin—kidney cancer	8.51e-05	0.000575	CcSEcCtD
Pentosan Polysulfate—Pruritus—Capecitabine—kidney cancer	8.46e-05	0.000571	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Doxorubicin—kidney cancer	8.45e-05	0.00057	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Capecitabine—kidney cancer	8.18e-05	0.000552	CcSEcCtD
Pentosan Polysulfate—Myalgia—Doxorubicin—kidney cancer	8.04e-05	0.000542	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Doxorubicin—kidney cancer	8.04e-05	0.000542	CcSEcCtD
Pentosan Polysulfate—Discomfort—Doxorubicin—kidney cancer	7.94e-05	0.000536	CcSEcCtD
Pentosan Polysulfate—Dizziness—Capecitabine—kidney cancer	7.9e-05	0.000533	CcSEcCtD
Pentosan Polysulfate—Oedema—Doxorubicin—kidney cancer	7.7e-05	0.00052	CcSEcCtD
Pentosan Polysulfate—Infection—Doxorubicin—kidney cancer	7.65e-05	0.000517	CcSEcCtD
Pentosan Polysulfate—Vomiting—Capecitabine—kidney cancer	7.6e-05	0.000513	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Doxorubicin—kidney cancer	7.54e-05	0.000509	CcSEcCtD
Pentosan Polysulfate—Rash—Capecitabine—kidney cancer	7.54e-05	0.000509	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Capecitabine—kidney cancer	7.53e-05	0.000508	CcSEcCtD
Pentosan Polysulfate—Headache—Capecitabine—kidney cancer	7.49e-05	0.000505	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Doxorubicin—kidney cancer	7.45e-05	0.000503	CcSEcCtD
Pentosan Polysulfate—Anorexia—Doxorubicin—kidney cancer	7.34e-05	0.000496	CcSEcCtD
Pentosan Polysulfate—Nausea—Capecitabine—kidney cancer	7.1e-05	0.000479	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Doxorubicin—kidney cancer	7.02e-05	0.000474	CcSEcCtD
Pentosan Polysulfate—Insomnia—Doxorubicin—kidney cancer	6.97e-05	0.00047	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Doxorubicin—kidney cancer	6.92e-05	0.000467	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Doxorubicin—kidney cancer	6.87e-05	0.000464	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Doxorubicin—kidney cancer	6.78e-05	0.000458	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Doxorubicin—kidney cancer	6.7e-05	0.000452	CcSEcCtD
Pentosan Polysulfate—Constipation—Doxorubicin—kidney cancer	6.59e-05	0.000445	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Doxorubicin—kidney cancer	6.35e-05	0.000428	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Doxorubicin—kidney cancer	6.3e-05	0.000425	CcSEcCtD
Pentosan Polysulfate—Urticaria—Doxorubicin—kidney cancer	6.12e-05	0.000413	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Doxorubicin—kidney cancer	6.09e-05	0.000411	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Doxorubicin—kidney cancer	5.68e-05	0.000383	CcSEcCtD
Pentosan Polysulfate—Pruritus—Doxorubicin—kidney cancer	5.45e-05	0.000368	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Doxorubicin—kidney cancer	5.27e-05	0.000356	CcSEcCtD
Pentosan Polysulfate—Dizziness—Doxorubicin—kidney cancer	5.09e-05	0.000344	CcSEcCtD
Pentosan Polysulfate—Vomiting—Doxorubicin—kidney cancer	4.9e-05	0.000331	CcSEcCtD
Pentosan Polysulfate—Rash—Doxorubicin—kidney cancer	4.86e-05	0.000328	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Doxorubicin—kidney cancer	4.85e-05	0.000328	CcSEcCtD
Pentosan Polysulfate—Headache—Doxorubicin—kidney cancer	4.83e-05	0.000326	CcSEcCtD
Pentosan Polysulfate—Nausea—Doxorubicin—kidney cancer	4.58e-05	0.000309	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling Pathways—CTNNA1—kidney cancer	2.64e-05	0.000154	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EIF4EBP1—kidney cancer	2.63e-05	0.000154	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HSPB1—kidney cancer	2.63e-05	0.000154	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—RAF1—kidney cancer	2.62e-05	0.000153	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—RELA—kidney cancer	2.61e-05	0.000152	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—ERBB2—kidney cancer	2.59e-05	0.000151	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CD8A—kidney cancer	2.59e-05	0.000151	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—KRAS—kidney cancer	2.57e-05	0.00015	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—MTOR—kidney cancer	2.56e-05	0.000149	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CD4—kidney cancer	2.56e-05	0.000149	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CDKN2B—kidney cancer	2.55e-05	0.000149	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—RAF1—kidney cancer	2.52e-05	0.000147	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—RELA—kidney cancer	2.51e-05	0.000146	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—PIK3CA—kidney cancer	2.5e-05	0.000146	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—ERBB2—kidney cancer	2.49e-05	0.000145	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—PIK3CA—kidney cancer	2.46e-05	0.000144	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—MTOR—kidney cancer	2.46e-05	0.000144	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CD4—kidney cancer	2.45e-05	0.000143	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PSMD7—kidney cancer	2.44e-05	0.000143	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ANXA1—kidney cancer	2.44e-05	0.000143	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TSC1—kidney cancer	2.44e-05	0.000143	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CTNNA1—kidney cancer	2.41e-05	0.000141	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—RAF1—kidney cancer	2.41e-05	0.00014	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CDKN1B—kidney cancer	2.4e-05	0.00014	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HSPB1—kidney cancer	2.4e-05	0.00014	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EIF4EBP1—kidney cancer	2.4e-05	0.00014	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—RELA—kidney cancer	2.4e-05	0.00014	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—RAF1—kidney cancer	2.39e-05	0.00014	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—RELA—kidney cancer	2.38e-05	0.000139	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—ERBB2—kidney cancer	2.38e-05	0.000139	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FLT1—kidney cancer	2.37e-05	0.000138	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—ERBB2—kidney cancer	2.37e-05	0.000138	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD8A—kidney cancer	2.36e-05	0.000138	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—PIK3CA—kidney cancer	2.36e-05	0.000138	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—MTOR—kidney cancer	2.35e-05	0.000137	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CD4—kidney cancer	2.34e-05	0.000137	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—CTNNB1—kidney cancer	2.34e-05	0.000137	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—MTOR—kidney cancer	2.33e-05	0.000136	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CD4—kidney cancer	2.33e-05	0.000136	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CDKN2B—kidney cancer	2.33e-05	0.000136	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CDKN1B—kidney cancer	2.31e-05	0.000135	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—RAF1—kidney cancer	2.3e-05	0.000134	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—JUN—kidney cancer	2.29e-05	0.000134	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—RELA—kidney cancer	2.29e-05	0.000133	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—ERBB2—kidney cancer	2.27e-05	0.000133	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CTNNB1—kidney cancer	2.27e-05	0.000133	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HIF1A—kidney cancer	2.25e-05	0.000131	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TSC2—kidney cancer	2.24e-05	0.000131	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—MTOR—kidney cancer	2.24e-05	0.000131	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CD4—kidney cancer	2.24e-05	0.000131	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TSC1—kidney cancer	2.23e-05	0.00013	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ANXA1—kidney cancer	2.23e-05	0.00013	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PSMD7—kidney cancer	2.23e-05	0.00013	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—RAF1—kidney cancer	2.22e-05	0.00013	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—PTEN—kidney cancer	2.21e-05	0.000129	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CDKN1B—kidney cancer	2.2e-05	0.000129	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—TSC2—kidney cancer	2.2e-05	0.000129	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—ERBB2—kidney cancer	2.2e-05	0.000128	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—JUNB—kidney cancer	2.19e-05	0.000128	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PAK1—kidney cancer	2.19e-05	0.000128	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CDKN1B—kidney cancer	2.19e-05	0.000128	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MTOR—kidney cancer	2.17e-05	0.000127	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CD4—kidney cancer	2.16e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FLT1—kidney cancer	2.16e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL2—kidney cancer	2.16e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KDR—kidney cancer	2.15e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PTGS2—kidney cancer	2.15e-05	0.000125	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—PTEN—kidney cancer	2.12e-05	0.000124	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CDKN1B—kidney cancer	2.1e-05	0.000123	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—JUN—kidney cancer	2.1e-05	0.000123	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—JUN—kidney cancer	2.09e-05	0.000122	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CTNNB1—kidney cancer	2.08e-05	0.000122	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CTNNB1—kidney cancer	2.07e-05	0.000121	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—VEGFA—kidney cancer	2.06e-05	0.00012	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HIF1A—kidney cancer	2.04e-05	0.000119	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CDKN1B—kidney cancer	2.04e-05	0.000119	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—TSC2—kidney cancer	2.03e-05	0.000119	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—PTEN—kidney cancer	2.03e-05	0.000119	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—PTEN—kidney cancer	2.02e-05	0.000118	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—TSC2—kidney cancer	2.01e-05	0.000117	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PAK1—kidney cancer	2e-05	0.000117	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—JUNB—kidney cancer	2e-05	0.000117	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KIT—kidney cancer	1.98e-05	0.000116	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—APC—kidney cancer	1.98e-05	0.000116	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—MAPK3—kidney cancer	1.95e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KIT—kidney cancer	1.95e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—PTEN—kidney cancer	1.94e-05	0.000113	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CTNNB1—kidney cancer	1.92e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—MAPK3—kidney cancer	1.89e-05	0.00011	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—POMC—kidney cancer	1.89e-05	0.00011	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PTEN—kidney cancer	1.87e-05	0.000109	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—BRAF—kidney cancer	1.86e-05	0.000109	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HIF1A—kidney cancer	1.86e-05	0.000109	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—MAPK1—kidney cancer	1.86e-05	0.000108	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—TSC2—kidney cancer	1.86e-05	0.000108	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—MAPK1—kidney cancer	1.8e-05	0.000105	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—KIT—kidney cancer	1.8e-05	0.000105	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—APC—kidney cancer	1.8e-05	0.000105	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IGF2—kidney cancer	1.79e-05	0.000105	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDH1—kidney cancer	1.79e-05	0.000105	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CDKN2B—kidney cancer	1.79e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KIT—kidney cancer	1.77e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—KRAS—kidney cancer	1.75e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IGF1R—kidney cancer	1.73e-05	0.000101	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—MAPK3—kidney cancer	1.73e-05	0.000101	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—MAPK3—kidney cancer	1.72e-05	0.000101	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—KRAS—kidney cancer	1.7e-05	9.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—BRAF—kidney cancer	1.69e-05	9.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—MAPK1—kidney cancer	1.65e-05	9.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—MAPK1—kidney cancer	1.64e-05	9.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—KIT—kidney cancer	1.64e-05	9.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—APC—kidney cancer	1.64e-05	9.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IGF2—kidney cancer	1.64e-05	9.55e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDH1—kidney cancer	1.63e-05	9.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—KRAS—kidney cancer	1.63e-05	9.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CDKN2B—kidney cancer	1.63e-05	9.51e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MAPK3—kidney cancer	1.6e-05	9.35e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IGF1R—kidney cancer	1.58e-05	9.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—PIK3CA—kidney cancer	1.56e-05	9.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—KRAS—kidney cancer	1.56e-05	9.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MYC—kidney cancer	1.56e-05	9.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—RAF1—kidney cancer	1.56e-05	9.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—KRAS—kidney cancer	1.55e-05	9.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—RELA—kidney cancer	1.55e-05	9.04e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—BRAF—kidney cancer	1.54e-05	8.99e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ERBB2—kidney cancer	1.54e-05	8.99e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—RAF1—kidney cancer	1.53e-05	8.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MAPK1—kidney cancer	1.52e-05	8.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—RELA—kidney cancer	1.52e-05	8.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MTOR—kidney cancer	1.52e-05	8.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—ERBB2—kidney cancer	1.51e-05	8.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—PIK3CA—kidney cancer	1.5e-05	8.75e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MTOR—kidney cancer	1.49e-05	8.71e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CD4—kidney cancer	1.49e-05	8.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—KRAS—kidney cancer	1.49e-05	8.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—KRAS—kidney cancer	1.44e-05	8.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—PIK3CA—kidney cancer	1.43e-05	8.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HIF1A—kidney cancer	1.43e-05	8.34e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CDKN1B—kidney cancer	1.43e-05	8.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TSC2—kidney cancer	1.42e-05	8.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—PIK3CA—kidney cancer	1.42e-05	8.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—RAF1—kidney cancer	1.41e-05	8.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDKN1B—kidney cancer	1.4e-05	8.17e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—ERBB2—kidney cancer	1.39e-05	8.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL2—kidney cancer	1.39e-05	8.14e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—RAF1—kidney cancer	1.39e-05	8.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—RELA—kidney cancer	1.39e-05	8.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ERBB2—kidney cancer	1.38e-05	8.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MTOR—kidney cancer	1.38e-05	8.04e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CD4—kidney cancer	1.37e-05	8.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL2—kidney cancer	1.37e-05	8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—PIK3CA—kidney cancer	1.37e-05	7.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KDR—kidney cancer	1.37e-05	7.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTGS2—kidney cancer	1.36e-05	7.97e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCND1—kidney cancer	1.36e-05	7.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MTOR—kidney cancer	1.36e-05	7.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD4—kidney cancer	1.36e-05	7.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—JUN—kidney cancer	1.36e-05	7.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CTNNB1—kidney cancer	1.35e-05	7.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—JUN—kidney cancer	1.33e-05	7.78e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PIK3CA—kidney cancer	1.32e-05	7.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CTNNB1—kidney cancer	1.32e-05	7.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PTEN—kidney cancer	1.31e-05	7.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HIF1A—kidney cancer	1.3e-05	7.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TSC2—kidney cancer	1.3e-05	7.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CDKN1B—kidney cancer	1.29e-05	7.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PTEN—kidney cancer	1.29e-05	7.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—RAF1—kidney cancer	1.29e-05	7.51e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDKN1B—kidney cancer	1.28e-05	7.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—ERBB2—kidney cancer	1.27e-05	7.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—APC—kidney cancer	1.26e-05	7.35e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KIT—kidney cancer	1.26e-05	7.35e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MTOR—kidney cancer	1.26e-05	7.33e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CD4—kidney cancer	1.25e-05	7.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL2—kidney cancer	1.25e-05	7.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KDR—kidney cancer	1.25e-05	7.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTGS2—kidney cancer	1.24e-05	7.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CTNNB1—kidney cancer	1.22e-05	7.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—JUN—kidney cancer	1.21e-05	7.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CTNNB1—kidney cancer	1.21e-05	7.04e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—POMC—kidney cancer	1.2e-05	6.99e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTEN—kidney cancer	1.19e-05	6.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—VEGFA—kidney cancer	1.19e-05	6.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—BRAF—kidney cancer	1.18e-05	6.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CDKN1B—kidney cancer	1.18e-05	6.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PTEN—kidney cancer	1.17e-05	6.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—APC—kidney cancer	1.15e-05	6.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KIT—kidney cancer	1.15e-05	6.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MAPK3—kidney cancer	1.12e-05	6.55e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CTNNB1—kidney cancer	1.11e-05	6.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MAPK3—kidney cancer	1.1e-05	6.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—POMC—kidney cancer	1.09e-05	6.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MYC—kidney cancer	1.09e-05	6.37e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTEN—kidney cancer	1.08e-05	6.33e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—BRAF—kidney cancer	1.08e-05	6.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MAPK1—kidney cancer	1.07e-05	6.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MAPK1—kidney cancer	1.05e-05	6.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MAPK3—kidney cancer	1.02e-05	5.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KRAS—kidney cancer	1.01e-05	5.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MAPK3—kidney cancer	1e-05	5.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KRAS—kidney cancer	9.89e-06	5.78e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MYC—kidney cancer	9.89e-06	5.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—RAF1—kidney cancer	9.87e-06	5.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—RELA—kidney cancer	9.83e-06	5.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ERBB2—kidney cancer	9.77e-06	5.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MAPK1—kidney cancer	9.67e-06	5.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MTOR—kidney cancer	9.64e-06	5.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MAPK1—kidney cancer	9.55e-06	5.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MAPK3—kidney cancer	9.27e-06	5.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CA—kidney cancer	9.26e-06	5.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—KRAS—kidney cancer	9.13e-06	5.33e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CA—kidney cancer	9.09e-06	5.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CDKN1B—kidney cancer	9.05e-06	5.28e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KRAS—kidney cancer	9.02e-06	5.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MYC—kidney cancer	9.02e-06	5.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—RAF1—kidney cancer	9e-06	5.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—RELA—kidney cancer	8.96e-06	5.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TP53—kidney cancer	8.96e-06	5.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ERBB2—kidney cancer	8.91e-06	5.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL2—kidney cancer	8.85e-06	5.17e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MAPK1—kidney cancer	8.82e-06	5.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MTOR—kidney cancer	8.79e-06	5.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCND1—kidney cancer	8.63e-06	5.04e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—JUN—kidney cancer	8.61e-06	5.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CTNNB1—kidney cancer	8.55e-06	4.99e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CA—kidney cancer	8.39e-06	4.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PTEN—kidney cancer	8.33e-06	4.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—KRAS—kidney cancer	8.33e-06	4.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CA—kidney cancer	8.29e-06	4.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CDKN1B—kidney cancer	8.25e-06	4.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL2—kidney cancer	8.07e-06	4.71e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCND1—kidney cancer	7.87e-06	4.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—JUN—kidney cancer	7.85e-06	4.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CTNNB1—kidney cancer	7.79e-06	4.55e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CA—kidney cancer	7.65e-06	4.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PTEN—kidney cancer	7.6e-06	4.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VEGFA—kidney cancer	7.52e-06	4.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MAPK3—kidney cancer	7.12e-06	4.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MYC—kidney cancer	6.92e-06	4.04e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VEGFA—kidney cancer	6.86e-06	4.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MAPK1—kidney cancer	6.77e-06	3.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MAPK3—kidney cancer	6.49e-06	3.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KRAS—kidney cancer	6.4e-06	3.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MYC—kidney cancer	6.31e-06	3.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MAPK1—kidney cancer	6.18e-06	3.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CA—kidney cancer	5.88e-06	3.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KRAS—kidney cancer	5.83e-06	3.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TP53—kidney cancer	5.69e-06	3.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CA—kidney cancer	5.36e-06	3.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TP53—kidney cancer	5.18e-06	3.03e-05	CbGpPWpGaD
